|
|
|
| Headlines |
|
Conventional journals' truly unconventional "discoveries" (HTM, PDF)
Logical Biology heads on against Nature over ethical communication on iPS cell research (HTM, PDF)
Nature does not allow self-promotion of truth! (HTM, PDF)
Nature deleted Shi Liu's comment, again! (HTM, PDF)
Scientist sues journal over truth and defamation (HTM, PDF)
Indistinguishable PCR bands in a Science report on Yamanaka's new iPS cells (HTM, PDF)
Shi Liu's comments hidden by Nature (HTM)
A public comment on NIH guidelines for human stem cell research (HTM, PDF)
Top rejections (HTM, PDF)
Shi V. Liu’s Criticisms on iPS Cell Research (HTM, PDF)
Cancer Cell Formation by iPS Techniques: Mechanisms and Testing Approaches (HTM, PDF)
Complaint against Nature's Cherry-Picking against Truth And Discrimination against Truth-Seeking Scientists (HTM,PDF)
What is going on in Nature?(HTM, PDF)
|
| Shi V. Liu's World-First Important Discoveries(刘实世界第一的�大�现) |
|
Descriptin in English (HTM, PDF) and Chinese (HTM, PDF)
|
| Shi V. Liu's views on some key scientific topics and issues |
|
Aging (HTM, PDF), Cloning (HTM, PDF), Stem cells (HTM, PDF), Cancer (HTM, PDF), Evolution (HTM, PDF), Watson (HTM, PDF), Nobel Prize (HTM, PDF), Citation and Impact Factor (HTM, PDF), Reinvention and credit robbery (HTM, PDF), iPS Fast Track (HTM, PDF), iPS Top Spinning (HTM, PDF), Rejections by Cell (HTM, PDF),
|
| Publications by Razvan Tudor Radulescu in IM1 TFCP Journals |
|
Title list (HTM, PDF),Open access articles on the role of RB in aging and cancer (HTM, PDF) , on the prion protein/disease (HTM, PDF) and on rheumatoid arthritis (HTM, PDF). Evaluations (HTM)
|
| 刘实ä¸æ–‡æ–‡ç« (Shi V. Liu’s Publications in Chinese) |
|
æ–‡ç« ç›®å½•(List of Articles) (HTM, PDF)
|
| Revolution in Scientific Publishing |
|
TFCP Declaration: in English (HTM, PDF), in Chinese ä¸æ–‡(HTM,PDF)
Others' publications: Integrity of Research (Alberts), Reinventing the biomedical journal (Smith), Do not use impact factor for evaluating research (Seglen)
|
| Category |
Issue(s) |
Article(s) |
|
2 |
2 |
|
|
11 |
0 |
|
|
|
|
|
